Search Results - "Cho, Naoki"
-
1
Formation of reactive metabolites of benzbromarone in humanized-liver mice
Published in Drug metabolism and pharmacokinetics (01-12-2022)“…Benzbromarone, a uricosuric drug, has the potential to cause serious hepatotoxicity. Several studies have shown the formation of reactive metabolites of…”
Get full text
Journal Article -
2
Identification of novel glutathione adducts of benzbromarone in human liver microsomes
Published in Drug metabolism and pharmacokinetics (01-02-2017)“…Benzbromarone (BBR) is a potent uricosuric drug that can cause serious liver injury. Our recent study suggested that 1′-hydroxy BBR, one of major metabolites…”
Get full text
Journal Article -
3
Safety, Tolerability, and Pharmacokinetics of a Novel Oral Phosphodiesterase 4 Inhibitor, ME3183: First‐in‐Human Phase 1 Study
Published in Clinical pharmacology in drug development (01-04-2024)“…A novel, oral phosphodiesterase 4 (PDE4) inhibitor, ME3183, is under development for the treatment of psoriasis, atopic dermatitis, and other inflammatory…”
Get full text
Journal Article -
4
ME3183, a novel phosphodiesterase-4 inhibitor, exhibits potent anti-inflammatory effects and is well tolerated in a non-clinical study
Published in European journal of pharmacology (05-01-2024)“…Phosphodiesterase 4 (PDE4) inhibitors are expected to exhibit efficacy against inflammatory diseases due to their broad pharmacological activity. The launched…”
Get full text
Journal Article -
5
Empirical and theoretical approaches for the prediction of human hepatic clearance using chimeric mice with humanised liver: the use of physiologically based scaling, a novel solution for potential overprediction due to coexisting mouse metabolism
Published in Xenobiotica (02-09-2021)“…Chimeric mice are immunodeficient mice in which the majority of the hepatic parenchymal cells are replaced with human hepatocytes. Following intravenous…”
Get full text
Journal Article -
6
Selection of the candidate compound at an early stage of new drug development: retrospective pharmacokinetic and metabolic evaluations of valsartan using common marmosets
Published in Xenobiotica (03-06-2022)“…Valsartan is an antihypertensive drug that was developed using common marmosets (Callithrix jacchus) in pivotal toxicity studies as a non-rodent species. The…”
Get full text
Journal Article -
7
Association of a reactive intermediate derived from 1′,6‐dihydroxy metabolite with benzbromarone‐induced hepatotoxicity
Published in Journal of biochemical and molecular toxicology (01-10-2017)“…Treatment with benzbromarone can be associated with liver injury, but the detailed mechanism remains unknown. Our recent studies demonstrated that…”
Get full text
Journal Article